期刊文献+

两种非传统解剖外旁路手术治疗髂股动脉长段硬化闭塞症 被引量:2

Treatment of long-segment iliofemoral occlusive disease: two extra-anatomic bypass surgeries
原文传递
导出
摘要 目的评价健侧髂外动脉-患侧恫动脉人工血管移植交叉转流术(EIP)和健侧股-患侧股深动脉交叉转流术(FDF)治疗髂股动脉长段硬化闭塞症的疗效。方法本组85例患者为1995年7月至2009年12月接受治疗的髂股动脉长段硬化闭塞症患者。其中男性6l例,女性24例;年龄64-91岁,平均年龄75岁。按Fontaine分期,Ⅱb-Ⅲ期62例(72.9%),Ⅳ期23例(27.1%)。根据患肢股深动脉及膝上、下胴动脉显影状况,分别采用EIP(49例)、FDF(36例)进行治疗。比较两组患者转流术后患肢溃疡、截趾创面愈合、踝肱指数、患肢血流速度,以及1、3、5年累积通畅率和3、5年保肢率。结果围手术期无死亡及截肢患者。74例(87.1%)获得随访;随访2-13年,平均5.7年。FDF组与EIP组术后踝肱指数分别为0.52±0.11和0.94±0.13(t=-21.88,P=0.000)。FDF组与EIP组术后血管多普勒超声检测胭动脉血流速度为(32±9)cm/s和(48±4)cm/s(t=16.76,P=0.000),胫前(后)动脉血流速度为(22±7)cm/s和(42±4)cm/s(t=10.50,P=0.00)。FDF组与EIP组术后1、3、5年一二期累积通畅率分别为87.8%、80.7%、68.4%和88.3%、81.2%、57.4%,术后3、5年保肢率分别为87.6%、76.7%和88.6%、71.3%,两组比较差异无统计学意义(P均〉0.05)。,结论FDF、EIP这两种解剖外旁路手术治疗单侧髂总一股浅动脉硬化闭塞症安全有效,尤其适宜高危老年患者。 Objective To report and evaluate the clinical results of surgical treatment fbr long- segment iliofemoral arteriosclerosis obliterans, including extelaaal iliac-popliteal (EIP) and femoral-deep femoral (FDF) crossover bypass surgeries. Methods From July 1995 to December 2009, 85 patients (61 male, 24 female, aged from 64 to 91 years, mean age 75 years) with comprehensive unilateral lilac- superficial femoral arteriosclerosis obliterans were involved in this research. According to Fontaine classification, the 85 patients could be graded as 62 class Ⅱb-Ⅲ patients (72.9%) , and 23 class Ⅳ patients (27.1% ). In CT angiography or DSA examinations, the 85 patients were grouped into EIP ( n = 49) and FDF (n = 36) surgical groups on the basis of visualizations in the affected deep femoral, supra- knee/infra-knee popliteal arteries. The healing time of ulcers and toe amputation wound, ankle-brachial index, and blood flow velocity in the affected limb together with accumulative patency rates in 1 , 3 and 5 years and limb salvage rates in 3 and 5 years were analyzed. Results None of the 85 patients died or had extremity amputated in perioperatively. Seventy-four patients ( 87. 1% ) had been followed up from 2 to 13 years (mean 5.7 years). Postoperative ankle-brachial index of FDF and EIP groups was 0. 55±0. 11, and 0. 94±0. 13 (t = -21.88, P = 0. 000). Postoperative velocity of popliteal artery blood flow in FDF and EIP groups was (32 +9) cm/s, and (48-+ 4) cm/s (t = 16. 76, P = 0. 000); velocity of anterior or posterior tibial artery was (22 +7) cm/s, and (42 _+4) cm/s (t = 10. 50, P =0. 000). The primary and secondary patency rates of FDF and EIP groups were 87.8% and 88.3% , 80. 7% and 81.2% , 68.4% and57. 4% at 1, 3 and 5 years, respectively. Limb salvage rates of FDF and EIP groups were 87.6% and 88.6%, 76.7% and 71.3%, at 3 and 5 years, respectively. There were no statistically significant differences in 1, 3, and 5 years' cumulative secondary patency rate and limb salvage rate between FDF and EIP groups. Conclusions As extra-anatomic bypass surgeries, FDF and EIP are both determined to be alternative procedures for unilateral common iliae-superficial femoral artery occlusive disease, especially suitable for high-risk patients. EIP group patients have better clinical outcomes than those in FDF group.
出处 《中华外科杂志》 CAS CSCD 北大核心 2012年第4期306-309,共4页 Chinese Journal of Surgery
关键词 动脉硬化 闭塞性 髂动脉 股动脉血管外科手术 血管假体植入 Arteriosclerosis, obliterans Iliacartery Femoral artery Vascular surgicalprocedures Blood vessel prosthesis implantation
  • 相关文献

参考文献11

  • 1马杰,马韬.髂外-腘动脉人工血管交叉转流术治疗髂股动脉硬化闭塞症[J].中华普通外科杂志,2009,24(8):625-627. 被引量:4
  • 2马杰 张晓春 张立擘 等.股—股深动脉转流术治疗动脉硬化闭塞症[J].中华外科杂志,1999,37:230-230.
  • 3Norgren L,Hiatt WR,Dormandy JA,et al.Inter-Society Consensus for the Managenment of Peripheral Arterial Disease(TASC Ⅱ).J Vasc Surg,2007,45 Suppl S:S5-67.
  • 4Daenens K,Maleux G,Fourneau I,et al.Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease.J Cardiovasc Surg (Torino),2005,46:25-29.
  • 5Lenti M,Cieri E,De Rango P,et al.Endovascular treatment of long lesions of the superficial femoral artery:results from a multicenter registry of a spiral,covered polytetrafluoroethylene stent.J Vasc Surg,2007,45:32-39.
  • 6Mingoli A,Sapienza P,Feldhaus RJ,et al.Comparison of femorofemoral and aortofemoral bypass for aotoiliac occlusive disease.J Cardiovasc Surg (Torion),2001,42:381-387.
  • 7Martin D,Katz SG.Axillofemoral bypass for aortoiliac occlusive disease.Am J Surg,2000,180:100-103.
  • 8吴庆华,杨培.论TASC分型与下肢动脉硬化闭塞的治疗选择[J].中华普通外科杂志,2009,24(6):433-435. 被引量:15
  • 9Green RM,Abbott WM,Matsumoto T,et al.Prosthetic above-knee femoropopliteal bypass grafting:five-year restlts of a randomized trial.J Vasc Surg,2000,31:417-425.
  • 10Burger DH,Kappeteir AP,Van Bockel JH,et al.A prospectixe randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting.J Vasc Surg,2000,32:272-283.

二级参考文献17

  • 1吴庆华.下肢动脉硬化闭塞症手术和介入治疗适应症的选择[J].中国中西医结合外科杂志,2005,11(2):97-100. 被引量:25
  • 2杨宝钟,吴庆华,韩延民,陈忠,霍昕.腹膜后途径行主髂动脉重建的体会[J].中华外科杂志,2005,43(14):926-928. 被引量:3
  • 3吴庆华.重视血管外科手术并发症的预防和处理[J].中华普通外科杂志,2005,20(9):547-548. 被引量:7
  • 4罗小云,吴庆华,陈忠.动脉硬化性主髂动脉闭塞症血管重建的术式选择[J].中华普通外科杂志,2006,21(2):102-104. 被引量:13
  • 5Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg, 2007,45 Suppl S:S5-67.
  • 6Stoffers HE, Rinkens PE, Kester AD, et al. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol, 1996, 25:282-290.
  • 7Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the. elderly : the rotterdam study. Arterioscler Thromb Vasc Biol, 1998,18 : 185-192.
  • 8Aquino R, Johnnldes C, Makaroun M, et al. Natural history of claudication : Long-term serial follow-up study of 1244 claudicants. J Vasc Surg, 2001, 34:962-970.
  • 9Luther M, Kantonen I , Lepantalo M, et al. Arterial intervention and reduction in amputation for chronic critical leg ischemia. Br J Surg, 2000, 87: 454-458.
  • 10Mingoli A, Sapienza P, Feldhaus RJ, et al. Comparison of femorofemoral and aortofemoral bypass for aotoiliac occlusive disease. J Cardiovasc Surg, 2001, 42:381-387.

共引文献40

同被引文献36

  • 1Devine C, McCollum C. Heparin-bonded dacron or polytetrafluorethylene for femoropopliteal bypass: five- year results of a prospective randomized multicenter clini- cal trial [ J 1 ~ J Vasc Surg, 2004,40 ( 5 ) :924-931.
  • 2Kashyap V S, Pavkov M L, Bena J F, et al. The man- agement of severe aortoiliac occlusive disease: endovascu- lar therapy rivals open reconstruction [ J ]. J Vasc Surg, 2008,48 ( 6 ) : 1451-1457.
  • 3Mii S, Eguchi D, Talkenaka T, et al. Role of femorofem- oral crossover bypass grafting for unilateral iliac athero- sclerotic disease: a comparative evaluation with anatomic bypass[J]. Surg Today, 2005,35(6) :453-458.
  • 4Martin D, Katz S G. Axillofemoral bypass for aortoiliac occlusive disease [ J ]. Am J Surg, 2000,180 ( 2 ) : 100- 103.
  • 5Bradbury A W, Adam D J, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) tri- al: an intention-to-treat analysis of amputation-free and o- verall survival in patients randomized to a bypass surgery- first or a balloon angioplasty-first revascularization strate- gy[J]. J Vasc Surg, 2010,51 (5):5S-17S.
  • 6Sixt S, Krankenberg H, Mohrle C, et al. Endovascular treatment for extensive aortoiliac artery reconstruction: a single-center experience based on 1712 interventions [ J]. J Endovasc Ther. 2013.20( 1) ,64-73.
  • 7Shah P S, Hingorani A, Ascher E, et al. Full metal jacket stenting of the superficial femoral artery: a retro- spective review [ J]. Ann Vasc Surg, 2011,25 ( 1 ) : 127- 131.
  • 8Taneja M, Tay K H, Dewan A, et al. Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal pop- liteal artery in diabetic patients presenting with criticallimb ischemia [J]. Cardiovasc Revasc Med, 2010, 11 (4) :232-235.
  • 9Seali S T, Rzueidlo E M, Bjerke A A, et al. Long-term results of open and endovascular revaseularization of su- perficial femoral artery occlusive disease [ J ]. J Vase Surg, 2011,54(3) :714-721.
  • 10Schneider J R, Verta M J, Alonzo M J, et ul. Results with viabahn-assisted subintimal recanalization for TASC e and TASC d superficial femoral artery occlusive disease [ J]. Vase Endovaseular Surg, 2011,45(5) :391-397.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部